Other Viruses Citation List:
April 15 - April 28, 2011
Human cytomegalovirus
1. Synthesis, Metabolic Stability and Antiviral Evaluation of Various Alkoxyalkyl Esters of Cidofovir and 9-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]Adenine. Ruiz, J., J.R. Beadle, R. Mark Buller, J. Schreiwer, M.N. Prichard, K.A. Keith, K.C. Lewis, and K.Y. Hostetler. Bioorganic & Medicinal Chemistry, 2011. 19(9): p. 2950-2958; PMID[21493074].
[Pubmed]. OV_0415-042811.
Epstein-Barr virus
2. Inhibition of the Epstein-Barr Virus Lytic Cycle by Protoapigenone. Tung, C.P., F.R. Chang, Y.C. Wu, D.W. Chuang, A. Hunyadi, and S.T. Liu. The Journal of General Virology, 2011. [Epub ahead of print]; PMID[21490247].
[Pubmed]. OV_0415-042811.
Hepatitis A virus
3. Grape Seed Extract for the Control of Human Enteric Viruses. Su, X. and D.H. D'Souza. Applied and Environmental Microbiology, 2011. [Epub ahead of print]; PMID[21498749].
[Pubmed]. OV_0415-042811.
Hepatitis C virus
4. Resistance Mutations Define Specific Antiviral Effects for Inhibitors of the Hepatitis C Virus (Hcv) P7 Ion Channel. Foster, T.L., M. Verow, A.L. Wozniak, M.J. Bentham, J. Thompson, E. Atkins, S.A. Weinman, C. Fishwick, R. Foster, M. Harris, and S. Griffin. Hepatology (Baltimore, Md.), 2011. [Epub ahead of print]; PMID[21520195].
[Pubmed]. OV_0415-042811.
5. The Synthesis and Evaluation of a Novel Class of (E)-3-(1-Cyclohexyl-1h-Pyrazol-3-Yl)-2-Methylacrylic Acid Hepatitis C Virus Polymerase Ns5b Inhibitors. Martin, S.W., P. Glunz, B.R. Beno, C. Bergstrom, J.L. Romine, E. Scott Priestley, M. Newman, M. Gao, S. Roberts, K. Rigat, R. Fridell, D. Qiu, G. Knobloh, and Y.K. Wang. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21507645].
[Pubmed]. OV_0415-042811.
6. Hcv-Ns3/4a Protease Inhibitory Iridoid Glucosides and Dimeric Foliamenthoic Acid Derivatives from Anarrhinum Orientale. Salah El Dine, R., A.R. Abdel Monem, A.M. El-Halawany, M. Hattori, and E. Abdel-Sattar. Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21506603].
[Pubmed]. OV_0415-042811.
7. Selection, Optimisation and Pharmacokinetic Properties of a Novel, Potent Antiviral Locked Nucleic Acid (Lna-) Based Antisense Oligomer (Aso) Targeting Hepatitis C Virus (Hcv) Internal Ribosome Entry Site (Ires). Laxton, C., K. Brady, S. Moschos, P. Turnpenny, J. Rawal, D.C. Pryde, B. Sidders, R. Corbau, C. Pickford, and E.J. Murray. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21502629].
[Pubmed]. OV_0415-042811.
Citations from the ISI Web of Knowledge Listings for O.I.
8. Rational Design of a Novel Family of Non-Peptidic Cyclophylin Inhibitors That Potently Inhibit Hcv Replication by Fragment-Based Drug Design. Ahmed-Belkacem, A., L. Colliandre, Y. Bessin, P. Barthe, W. Bourguet, D. Douguet, N. Ahnou, J.M. Pawlotsky, and J.F. Guichou. Hepatology, 2010. 52(4): p. 1206A-1207A; ISI[000288775602482].
[WOS]. OV_0415-042811.
9. Novel Small-Molecule Hcv-Entry Inhibitors Block Virus Spread and Promote Virus Clearance in Vitro. de Muys, J.M., G. Coburn, A.O. Han, J.D. Murga, D. Fisch, D. Paul, S. Moorji, K. Provoncha, D. Qian, P.J. Maddon, and W.C. Olson. Hepatology, 2010. 52(4): p. 828A-829A; ISI[000288775601372].
[WOS]. OV_0415-042811.
10. Vitamin D Metabolites Inhibit Replication of the Hepatitis C Virus. Gutierrez, J.A., K.A. Jones, R.L. Fitzgerald, J. Allina, A.D. Branch, D.L. Trump, R.T. Schooley, and D.L. Wyles. Hepatology, 2010. 52(4): p. 704A-704A; ISI[000288775601122].
[WOS]. OV_0415-042811.
11. Chloroquine and Related Compounds Are Inhibitors of Hepatitis C Virus Rna-by Inhibiting Autophagy Proteolysis. Halfon, P., J.P. Nallet, S.J. Petit, M. Bouzid, F. Joly, C.J. Camus, P. Benech, J. Dubuisson, J. Courcambeck, and C. Wychowski. Hepatology, 2010. 52(4): p. 807A-807A; ISI[000288775601324]. [WOS]. OV_0415-042811.
12. Metabolite Characterization of Inx-189, a Potent Hcv Inhibitor, in Fresh Human Primary Hepatocytes and Human Liver and Kidney Cell Lines. Hall, A., N. Raja, S.D. Chamberlain, E. Gorovits, G.W. Henson, J.T. Hutchins, J. Muhammad, J. Patti, J. Vernachio, J. Wang, K. Madela, M. Aljarah, S.L. Jones, and C. McGuigan. Hepatology, 2010. 52(4): p. 1211A-1211A; ISI[000288775602492].
[WOS]. OV_0415-042811.
13. Ach-2684: Hcv Ns3 Protease Inhibitor with Potent Activity against Multiple Genotypes and Known Resistant Variants. Huang, M.J., S. Podos, D. Patel, G.W. Yang, J.L. Fabrycki, Y.S. Zhao, C. Marlor, P. Kapoor, X.Z. Wang, A. Hashimoto, V. Gadhachanda, G. Pais, D.W. Chen, A. Agarwal, M. Deshpande, K.L. Stauber, and A. Phadke. Hepatology, 2010. 52(4): p. 1204A-1204A; ISI[000288775602477].
[WOS]. OV_0415-042811.
14. Nonclinical Profile and Phase I Results in Healthy Volunteers for the Novel and Potent Hcv Ns5a Inhibitor Gs-5885. Link, J.O., R. Bannister, L.D. Beilke, G.F. Cheng, M. Cornpropst, A. Corsa, E. Dowdy, H.Y. Guo, D. Kato, T. Kirschberg, H.T. Liu, M. Mitchell, M. Matles, E. Mogalian, E. Mondou, C. Ohmstede, B. Peng, R.W. Scott, J.W. Findlay, G.E. Chittick, F. Wang, J. Alianti, J.Y. Sun, J. Taylor, Y. Tian, L.H. Xu, C. Yang, G.J. Yuen, K. Wang, and E.J. Eisenberg. Hepatology, 2010. 52(4): p. 1215A-1216A; ISI[000288775602501].
[WOS]. OV_0415-042811.
15. Synthesis and Biological Evaluation of Unsaturated Keto and Exomethylene D-Arabinopyranonucleoside Analogs: Novel 5-Fluorouracil Analogs That Target Thymidylate Synthase. Tzioumaki, N., S. Manta, E. Tsoukala, J.V. Voorde, S. Liekens, D. Komiotis, and J. Balzarini. European Journal of Medicinal Chemistry, 2011. 46(4): p. 993-1005; ISI[000289048400002].
[WOS]. OV_0415-042811.
16. In Vitro Combination Studies of Ach-1625 (Hcv Ns3 Protease Inhibitor) and Ach-2928 (Hcv Ns5a Inhibitor) in Presence and Absence of Ribavirin. Zhao, Y.S., G.W. Yang, J.L. Fabrycki, D. Patel, J. Wiles, X.Z. Wang, A. Phadke, M. Deshpande, and M.J. Huang. Hepatology. 52: p. 1214A-1214A; ISI[000288775602498].
[WOS]. OV_0415-042811.